Malignant Adnexal Tumor
Showing 1 - 25 of >10,000
Adnexal Mass, Adnexal Tumor, Adnexal Cyst Trial in Leuven (Ultrasound)
Recruiting
- Adnexal Mass
- +3 more
- Ultrasound
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Jul 25, 2023
Sebaceous Cell Tumor of Eyelid Trial in Roma (exome sequencing (retrospective) and exome and methylome sequencing (prospective))
Recruiting
- Sebaceous Cell Tumor of Eyelid
- exome sequencing (retrospective) and exome and methylome sequencing (prospective)
-
Roma, Rome, ItalyGustavo Savino
Oct 8, 2023
Melanoma, Breast Carcinoma, Hepatocellular Carcinoma Trial in United States (XmAb20717)
Completed
- Melanoma
- +27 more
- XmAb20717
-
Los Angeles, California
- +16 more
Nov 29, 2022
Gynecological Tumor Trial in Chengdu (Aprepitant Injection)
Not yet recruiting
- Gynecological Tumor
- Aprepitant Injection
-
Chengdu, Sichua, ChinaDengfeng Wang
Aug 22, 2023
Advanced Malignant Tumor Trial in Jinan (JS207)
Not yet recruiting
- Advanced Malignant Tumor
-
Jinan, Shandong, ChinaAffiliated Cancer Hospital of Shandong First Medical University
Aug 28, 2023
Circulating and Tumor-infiltrating Immune Cells in Malignant
Recruiting
- Brain Tumor, Primary
- Brain Tumor - Metastatic
- Circulating leukocytes immunophenotype
- Tumor sampling
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Apr 14, 2023
Malignant Tumor of Bone, Perioperative Period Trial (Tik Tok)
Not yet recruiting
- Malignant Tumor of Bone
- Perioperative Period
- Tik Tok
- (no location specified)
Jan 11, 2023
Cancer Ratio,Pleural Fluid Adenosine Deaminase,Lactate
Not yet recruiting
- Pleural Effusion, Malignant
- pleural markers
- (no location specified)
Jan 20, 2023
Advanced Solid Tumor Trial (SHR-4602 for injection)
Not yet recruiting
- Advanced Solid Tumor
- SHR-4602 for injection
- (no location specified)
Apr 6, 2023
Malignant Tumor Trial in Beijing (99mTc-CNDG SPECT/CT)
Recruiting
- Malignant Tumor
- 99mTc-CNDG SPECT/CT
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 3, 2023
Malignant Brain Tumor, Glioma, Coping Skills Trial in Boston (Information and Support Intervention, Usual supportive care)
Not yet recruiting
- Malignant Brain Tumor
- +2 more
- Information and Support Intervention
- Usual supportive care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jul 27, 2023
Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) Trial in Beijing (Sirolimus for Injection (Albumin Bound))
Recruiting
- Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
- Sirolimus for Injection (Albumin Bound)
-
Beijing, ChinaBeijing Jishuitan Hospital
Nov 23, 2022
Advanced Malignant Tumor Trial (SHR-5495 for injection)
Not yet recruiting
- Advanced Malignant Tumor
- SHR-5495 for injection
- (no location specified)
Sep 26, 2023
Advanced Malignant Solid Tumors Trial in Shanghai (HMPL-415S1)
Not yet recruiting
- Advanced Malignant Solid Tumors
-
Shanghai, Shanghai, ChinaZhongshan Hospital Fudan University
May 23, 2023
Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant
Recruiting
- Atypical Teratoid Rhabdoid Tumor
- +6 more
- Tazemetostat
- +2 more
-
Boston, Massachusetts
- +1 more
Jan 23, 2023
Medulloblastoma, CNS Tumor, Pediatric, Ependymoma Trial in Beijing
Recruiting
- Medulloblastoma
- +5 more
-
Beijing, Beijing, ChinaBeijing Tiantan Hosiptal
Jan 3, 2023
Advanced Malignant Tumor Trial (HRS-2189 Tablets)
Not yet recruiting
- Advanced Malignant Tumor
- HRS-2189 Tablets
- (no location specified)
May 6, 2023
BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)
Not yet recruiting
- BCC - Basal Cell Carcinoma
- +6 more
-
Marseille, FranceHôpital de la Timone
Jun 22, 2022
Cutaneous Tumor, Malignant Solid Tumor Trial (JCXH-211 Injection)
Not yet recruiting
- Cutaneous Tumor
- Malignant Solid Tumor
- JCXH-211 Injection
- (no location specified)
Feb 13, 2023
Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)
Not yet recruiting
- Advanced Malignant Solid Tumors
- Neoantigen peptide vaccine
- Neoantigen-based DC immune preparation
-
Nanchang, Jiangxi, ChinaFirst Affiliated Hospital of Nanchang University
Mar 1, 2023
HER2-positive Recurrent or Metastatic Malignant Solid Tumor Trial in Zhengzhou (Recombinant Humanized Bispecific Monoclonal
Recruiting
- HER2-positive Recurrent or Metastatic Malignant Solid Tumor
- Recombinant Humanized Bispecific Monoclonal Antibody MBS301
-
Zhengzhou, ChinaHenan Cancer Hospital
Nov 9, 2022
Different Ultrasound Methods for Discrimination Between Benign
Unknown status
- Patients With Adnexal Mass Prior to Surgery
- Standardized transvaginal ultrasound examination
-
Leuven, BelgiumUniversity Hospitals Leuven
Apr 12, 2020
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)
Not yet recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection(Revottack)+PD-1
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022
Malignant Tumor Trial (Experimental: DaRT seeds)
Not yet recruiting
- Malignant Tumor
- Experimental: DaRT seeds
- (no location specified)
Mar 27, 2023